Notícias

Nutrien Ltd. (NYSE:NTR) is one of the top cheap growth stocks to get rich. Berenberg downgraded Nutrien Ltd. (NYSE:NTR) to Hold from Buy on June 10 and adjusted the price target on the stock to $65, up from $61. It told investors in a research note that the company is likely to deliver another year of […]

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the top high-conviction stocks to buy according to hedge funds. Deutsche Bank cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $366 from $440 on June 2 while maintaining a Sell rating on the shares. The stock also received a rating update from BofA on May 12, […]

A lengthy dividend growth streak also usually means high quality, income stability, and the potential for above-average total returns over time.

Citizens has raised its price target on Backblaze to $14 from $8 and kept an ‘Outperform’ rating on the stock, according to TheFly.

An analysis of 30 of the most-hyped, tech-driven initial public offerings (IPOs) since May 2012 bodes poorly for SpaceX.

AbbVie’s model fair value is held at US$253.55 per share, signaling no change to the core price target after factoring in the proposed Apogee Therapeutics acquisition. Research around the US$10.9b deal points to a split view, with some analysts highlighting the immunology and atopic dermatitis opportunity, while others question how much value the company can capture against rising competition. As you read on, you will see how these mixed signals are shaping the evolving AbbVie story and what...

International Business Machines Corp. (NYSE:IBM) is one of the 10 Resilient Stocks Beating Market Slump. International Business Machines saw its share prices climb by 5.04 percent on Tuesday to close at $264.94 apiece, after JPMorgan turned bullish for its stock, thanks to the rosy prospects for its software business. In a market note, JPMorgan upgraded […]

I've covered Micron repeatedly, and each time, the story has been some version of the same thing. The artificial intelligence (AI) memory supercycle is getting bigger than the market expected, and Micron keeps proving the bears wrong. Tuesday, June 23, is a jarring interruption. MU dropped more ...

Axon Enterprise recently reported strong Q1 2026 results, raised its full-year revenue outlook, and continued winning long-term public safety contracts while facing local political controversy in Scottsdale over a proposed development project. The company is rapidly building an AI-powered public safety platform, spanning TASER 10, Axon Body 4, counter-drone systems, and tools like Axon Assistant and Axon Vision, that aims to lock in agencies through integrated hardware, software, and cloud...

Schrödinger, Inc. (NASDAQ:SDGR) is among the Best Pharmaceutical Stocks. On May 14, Morgan Stanley lowered its price target on Schrödinger, Inc. (NASDAQ:SDGR) to $17 from $19. The firm maintained an “Equal Weight” rating on the shares. Separately, Schrödinger, Inc. (NASDAQ:SDGR) maintained full-year guidance for ACV of $218 million to $228 million. The corporation expects 10% to […]

Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On May 14, Morgan Stanley increased its price objective on Generate Biomedicines, Inc. (NASDAQ:GENB) to $22 from $20. The firm maintained an “Overweight” rating on the shares. Separately, Generate Biomedicines, Inc. (NASDAQ:GENB)’s GB-0895 (anti-TSLP) program […]

Booking Holdings Inc. (NASDAQ:BKNG) is one of the most promising long-term stocks to buy according to analysts. On June 3, Priceline, a subsidiary and primary brand of Booking Holdings, upgraded its AI travel assistant, Penny, by integrating Anthropic’s Claude into its proprietary tech stack. This agentic tool allows users to move from initial travel ideas […]

Take-Two Interactive Software Inc (NASDAQ:TTWO) shares could see a stronger long-term monetization profile from the next iteration of Grand Theft Auto Online (GTAO), according to Bank of America, which raised its price objective on the stock and upgraded its forward bookings assumptions for the...

Lam Research is in focus as Citi’s $450 price target highlights the company’s potential from surging NAND demand.

BofA hiked its price target on Micron to $1,500 from $950, while keeping a ‘Buy’ rating.

SK hynix Inc. (OTC:HXSCL) is one of the fastest-growing high-bandwidth memory stocks to buy. The company gave the list one of its most direct HBM catalysts on June 17, 2026, when it shipped samples of 12-layer HBM4E to major customers. SK hynix said the next-generation AI memory reaches up to 16 Gbps per pin, improves […]

On Holding (ONON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Boston Scientific Corp. (NYSE:BSX) is one of the 10 oversold stocks offering high upside. On June 12, Matt O’Brien from Piper Sandler reduced the target price on Boston Scientific Corporation (NYSE:BSX) from $90 to $65, resulting in an adjusted upside potential of close to 45% at the current level. The analyst retained an Overweight rating […]

Chewy Inc. (NYSE:CHWY) is one of the 10 oversold stocks offering high upside. On June 12, Citi reaffirmed a Buy rating for Chewy Inc. (NYSE:CHWY) while reducing the price target from $37 to $31. Despite the downward adjustment, the estimated price target still results in an upside of almost 75%. According to the firm, the […]

IBM stock receives an upgrade to Buy at J.P. Morgan, with analysts citing growing confidence in its software business.

Investing.com -- Morgan Stanley upgraded CDW Corporation to Overweight and raised price targets across several IT hardware names, arguing that enterprise server demand is proving far more resilient than expected as companies accelerate investments in AI infrastructure and data center modernization.

Investing.com -- Wolfe Research reshuffled its U.S. retail coverage on Monday, upgrading Target to Outperform and selecting it as a top pick into year-end, while downgrading Home Depot and Five Below to Peer Perform.

IBM upgrade, SpaceX initiation among today's top calls on Wall Street

Analyst Downgrade Highlights Near-Term Execution RisksNike (NYSE:NKE) shares slipped 1. 4% in premarket trading on Tuesday after Evercore ISI downgraded the sportswear giant to In Line from Outperform and reduced its price target to $46 from $57.

KeyBanc lifted Marvell’s outlook, spotlighting data center networking as AI infrastructure’s strongest long-term growth driver.

Investing.com -- Piper Sandler upgraded semiconductor design software maker Synopsys to Overweight from Neutral and raised its price target to $550 from $450, citing improving prospects for the company's intellectual property (IP) business as Intel's foundry ambitions gain traction.

Investing.com -- Nike shares slipped 1.4% in premarket trading Tuesday after Evercore ISI downgraded the stock to In Line from Outperform and cut its price target to $46 from $57.

The latest research on Primary Health Properties centres on a refined £1.05 price target, set against an unchanged fair value estimate of £1.15 per share. Analysts expressing more constructive views see this £1.05 level as consistent with their confidence in the company’s long term profitability assumptions, while more cautious voices question how much upside that target really offers. As you read on, you will see how this evolving price target story fits into the wider analyst narrative and...

SMCI rose 28% in two days, notching its best two-day performance since May 2025.

Credo Technology Group Holding Ltd. (NASDAQ:CRDO) is one of the 10 Stocks Paying Off Big Time. Credo Technology rallied to a fresh all-time high on Monday, as investors took heart from an investment firm’s bullish coverage for its stock amid further rosy prospects from AI. In intra-day trading, the stock jumped to its highest price […]